BCL6-H2Kk-RV (H2K-BCL6)
(Plasmid
#40352)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 40352 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneMSCV2.1-H2Kk
-
Backbone manufacturerMark Kaplan
-
Modifications to backboneMouse H2K-k cDNA cloned after MSCV2.1 IRES
-
Vector typeMammalian Expression, Retroviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameBCL6
-
Alt nameBCL-6
-
Alt nameB-cell CLL/lymphoma 6
-
SpeciesH. sapiens (human)
-
GenBank IDNG_007149.1
-
Entrez GeneBCL6 (a.k.a. BCL5, BCL6A, LAZ3, ZBTB27, ZNF51)
-
Tag
/ Fusion Protein
- IRES mouse H2Kk (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BglII/BamHI (destroyed during cloning)
- 3′ cloning site BamHI/BglII (destroyed during cloning)
- 5′ sequencing primer pLXSN_5
- 3′ sequencing primer IRES-R2 (gacggcaatatggtggaaa) (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
A MSCV2.1 retroviral vector was modified by cloning of mouse H2K-k cDNA after the IRES sequence to make MSCV2.1-H2Kk. MSCV2.1-H2Kk was obtained from Dr. Mark Kaplan. MSCV2.1-H2Kk was then cut with BglII and a human BCL6 cDNA with BamHI ends was cloned into the BglII site.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
BCL6-H2Kk-RV (H2K-BCL6) was a gift from Alexander Dent (Addgene plasmid # 40352 ; http://n2t.net/addgene:40352 ; RRID:Addgene_40352) -
For your References section:
Transcriptional repressor BCL6 controls Th17 responses by controlling gene expression in both T cells and macrophages. Mondal A, Sawant D, Dent AL. J Immunol. 2010 Apr 15;184(8):4123-32. Epub 2010 Mar 8. 10.4049/jimmunol.0901242 PubMed 20212093